About 1.8 million doses of the new malaria drug, artesunate-amodiaquine, have been dispensed without serious side effects, Dr. Eugene K. Amable of the University of Ghana Medical School, has said.
He was speaking at the scientific session of the just ended 48 annual conference of the Ghana Medical Association (GMA) in Ho under the theme, "Environmental sanitation law and order and health".
Dr Amable said the drug had proved to be 97 percent effective against malaria as against chloroquine's 75 percent.
He said the drug was the first choice drug for the treatment of malaria in 19 African countries.
Dr Amable said the drug was subject to thorough scientific tests and evaluation and was found to be a better choice in terms of efficacy and cost.
He said it was scientifically wrong for the country to continue to depend on chloroquine for the treatment of malaria when its efficacy was assessed to be 75 percent.
NDC demands complete overhaul of security protocols at EC to safeguard electoral...
Ghana reaches interim deal with international bondholders — Finance Ministry
Mahama to form joint army-police anti-robbery squads to safeguard 24-hour econom...
Another man jailed eight months over shrinking penis
Ghana to adjust external bond deal to meet IMF debt sustainability goals — Finan...
IMF negotiations: We've not failed to reach an agreement with bondholders; we’ve...
EC begins recruitment of temporary electoral officials, closes on April 29
NPP lost the 2024 elections in 2022 due to inflation and cedi depreciation — Mar...
Your good heart towards Ghana has changed; don’t behave like Saul - Owusu Bempah...
Wa West: NDC organizes symposium for Vieri Ward Women
